Results

Total Results: 1,091 records

Showing results for "cardiovascular".
Users also searched for: statin

481. Prevention of Contrast Media Induced Nephropathy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/nephropathy-contrast-induced/research-protocol
     December 01, 2019 - Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular … High or moderate risk patients (as defined by clinical or demographic risk factors such as age, cardiovascular … information will include abstracts from the following professional society meetings: The Trans-catheter Cardiovascular … Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular … Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular

482. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
     July 01, 2013 - [Qsymia] patients had improved cardiovascular and metabolic risk factors and a decrease in the need … FDA has required the manufacturer to conduct 10 postmarketing requirements, including a long-term cardiovascular … 27.0–29.9 kg/m2) with at least one obesity-related comorbidity (e.g., hypertension, dyslipidemia, cardiovascular … Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants … Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function

483. Weight-Gain-Prevention Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
     January 01, 2020 - Obesity is a risk factor for chronic conditions including cardiovascular disease, type 2 diabetes, arthritis … cancer recurrence.16 Higher grades of obesity are associated with excess mortality, primarily from cardiovascular … a family history of obesity or diabetes mellitus, personal risk factors for diabetes mellitus and cardiovascular … Evidence Among Adults at Risk for or With Cardiovascular Disease or Diabetes Mellitus Eleven randomized … Multiple risk factors for cardiovascular disease and diabetes mellitus.

484. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research-protocol
     December 01, 2019 - levothyroxine therapy for subclinical hypothyroidism did not result in improved survival, decreased cardiovascular … What are the consequences of untreated subclinical thyroid disease, in particular related to cardiovascular … osteoporotic fractures Health outcomes: quality of life, cognitive function, neuropsychiatric symptoms, cardiovascular

485. The Effectiveness of Disease-Modifying Antirheumatic Drugs (DMARDS) in Children With Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/juvenile-arthritis-dmards/research-protocol
     December 01, 2019 - hepatotoxicity nephrotoxicity gastritis Etodolac Lodine NSAID No cardiovascular … gastritis hepatotoxicity nephrotoxicity Oxaprozin Daypro NSAID Yes cardiovascular … Effects of Omega-3 Fatty Acids on Cardiovascular Disease .

486. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/coronary-artery-stenting/research
     December 01, 2019 - Systematic Review Mar 03, 2025 Association of Digestible Carbohydrate Intake With Cardiovascular

487. Safety of Vaccines Used for Routine Immunization in the United States: An Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/safety-vaccines/research
     January 01, 2022 - Efficacy of Dental Services for Reducing Adverse Events in Those Undergoing Insertion of Implantable Cardiovascular

488. Telehealth: Mapping the Evidence for Patient Outcomes From Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/telehealth/technical-brief
     January 01, 2020 - telehealth is used for communication and counseling or remote monitoring in chronic conditions such as cardiovascular

489. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
     March 22, 2016 - associated with an increased risk of developing MCI and Alzheimer’s disease, including depression, cancer, cardiovascular … Examples include treatment and control of chronic medical or mental health conditions (i.e., cardiovascular … Alzheimer’s disease Interventions (examples) Aspirin/nonsteroidal anti-­inflammatory drugs (NSAIDS) Cardiovascular … We will examine the treatment of diseases such as cardiovascular disease, cerebrovascular disease, hypertension

490. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - [Qsymia] patients had improved cardiovascular and metabolic risk factors and a decrease in the need … FDA has required the manufacturer to conduct 10 postmarketing requirements, including a long-term cardiovascular … 27.0–29.9 kg/m2) with at least one obesity-related comorbidity (e.g., hypertension, dyslipidemia, cardiovascular … the-counter drugs, and herbal preparations have not been established  The effect of BELVIQ on cardiovascular … Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants

491. 1. What are the benefits and harms of rhythm control compared to rate control (including newer agents) ? What are the benefits and harms of strict vs more lenient rate control? 2. What are the benefits and harms of different… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-what-are-the-benefits-and-harms-of-rhythm-control-compared-to-rate-control-including-newer-agents-what-are-the-benefits-and-harms-of-strict-vs-more-lenient-rate-control-2-what-are-the-benefits-and-harms-of-different-antico
     November 01, 2017 - (check all that apply) EHC Priority Conditions (updated in 2008) Cardiovascular disease,

492. Supporting Patient and Consumer Involvement in Patient-Centered Outcomes Research (Video Presentation) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stakeholders-engagement-others/research
     November 01, 2017 - He also serves as a consumer stakeholder on AHRQ’s DEcIDE Cardiovascular Consortium, and has previously

493. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - Cardiovascular disease 4. Dementia (including Alzheimer’s Disease) 5. … to original research and news X Cardiology Today 1, 2, 4, 8, 9 Information source for cardiovascular … journal from the American Heart Association that publishes original medical research related to cardiovascular … Therapeutics) is the world's largest educational meeting specializing in interventional cardiovascular … information focusing on the development, sales, and marketing of major therapeutic categories - Cardiovascular

494. Nephropathy-Contrast-Induced Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
     October 01, 2013 - Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular … High or moderate risk patients (as defined by clinical or demographic risk factors such as age, cardiovascular … information will include abstracts from the following professional society meetings: The Trans-catheter Cardiovascular … Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular … Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular

495. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - Discrepancies between the cardiovascular findings from the Women’s Health Initiative clinical trial … controlled trial designed to evaluate the benefits and harms of aspirin therapy in relation to preventing cardiovascular … Similarly, if a cohort study enrolled current users and compared the rate of cardiovascular events for … hypertension may be part of the mechanism through which some COX-2 therapies increase the rate of cardiovascular … Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy

496. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - Celebrex NSAID Yes Hepatotoxicity; nephrotoxicity; gastritis Etodolac Lodine NSAID No Cardiovascular … Naprosyn Aleve NSAID Yes Gastritis; hepatotoxicity; nephrotoxicity Oxaprozin Daypro NSAID Yes Cardiovascular … Effects of Omega-3 Fatty Acids on Cardiovascular Disease.

497. S116 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - have a history of myocardial infarc- tion (PD � �0.7%), ischemic heart disease (PD � �1.6%), and other cardiovascular … Cardiac arrhythmia 223 1.5 Myocardial infarction 535 3.5 Other ischemic heart disease 3918 25.5 Other cardiovascular … Myocardial infarction �0.7 0.07 0.0 0.30 Other ischemic heart disease �1.6 0.09 �0.5 0.50 Other cardiovascular

498. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
     March 11, 2010 - levothyroxine therapy for subclinical hypothyroidism did not result in improved survival, decreased cardiovascular … What are the consequences of untreated subclinical thyroid disease, in particular related to cardiovascular … osteoporotic fractures • Health outcomes: quality of life, cognitive function, neuropsychiatric symptoms, cardiovascular

499. What evidence exists for programs to increase patient adherence to prescription medications? Which programs/approaches are most effective at increasing adherence for which populations and conditions? If little or no evidence exists, can… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-evidence-exists-for-programs-to-increase-patient-adherence-to-prescription-medications-which-programsapproaches-are-most-effective-at-increasing-adherence-for-which-populations-and-conditions-if-little-or-no-evidence-ex
     November 01, 2017 - (check all that apply) EHC Priority Conditions (updated in 2008) Cardiovascular disease, including

500. How can patients who have chronic diseases better prepare for critical illness and the end of life? Will a decision aid, using individualized estimates of outcomes, help shared decision making about advance care planning? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/how-can-patients-who-have-chronic-diseases-better-prepare-for-critical-illness-and-the-end-of-life-will-a-decision-aid-using-individualized-estimates-of-outcomes-help-shared-decision-making-about-advance-care-planning
     November 01, 2017 - (check all that apply) EHC Priority Conditions (updated in 2008) Cardiovascular disease, including